Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Psyence Group Inc (PSYG.CN)

Psyence Group Inc (PSYG.CN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 15,395
  • Shares Outstanding, K 85,529
  • Annual Sales, $ 0 K
  • Annual Income, $ -93 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.74
Trade PSYG.CN with:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.170 +5.88%
on 11/16/21
0.235 -23.40%
on 11/04/21
-0.020 (-10.00%)
since 10/26/21
3-Month
0.100 +80.00%
on 08/27/21
0.275 -34.55%
on 10/18/21
+0.050 (+38.46%)
since 08/26/21

Most Recent Stories

More News
Psyence Group Inc. files Q2 Unaudited Condensed Consolidated Interim Financial Statements and MD&A

TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.180 (-5.26%)
PSYGF : 0.1807 (+1.63%)
Psyence Group Invited as First Psychedelic Company to present at the 15th-Annual Global Wellness Summit

TORONTO, Nov. 26, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.180 (-5.26%)
OTC.VN : 0.540 (-1.82%)
Psyence Group Announces Commencement of Trading on OTCQB and DTC Eligibility of Common Shares in the United States Under the Ticker “PSYGF”

TORONTO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF) (“Psyence” or the “Company”), a life science biotechnology...

PSYG.CN : 0.180 (-5.26%)
OTC.VN : 0.540 (-1.82%)
Psyence Group Jamaica Chief Medical Officer Dr. Dingle Spence to Headline Two Conferences on Psychedelics

TORONTO, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE: PSYG) (“Psyence” or the “Company”), a life science biotechnology company pioneering...

PSYG.CN : 0.180 (-5.26%)
Pure Extracts and Psyence Group Form Joint Venture for Psychedelic Medicinal Mushroom Extracts

VANCOUVER, British Columbia, Sept. 28, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“ Pure Extracts ” or the “ Company ”) and Psyence...

PULL.CN : 0.135 (-3.57%)
PRXTF : 0.1130 (-3.42%)
PSYG.CN : 0.180 (-5.26%)
Proactive headlines including Kodiak Copper, Milestone Scientific, HempFusion Wellness and Major Precious Metals

New York , July 07, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in the US and Canada, has covered the following companies:

AZASF : 0.1580 (-1.62%)
CRDL : 2.16 (-2.26%)
CRTPF : 2.3000 (+5.50%)
MVMD.CN : 0.150 (-9.09%)
BHSC.CN : 0.375 (-1.32%)
CNVCF : 0.2956 (-3.49%)
TOMDF : 0.0800 (+44.14%)
BSGM : 3.08 (unch)
VEGA.CN : 0.300 (-6.25%)
CLSK : 17.26 (-4.54%)
PLTH.CN : 4.810 (-0.62%)
PLNHF : 3.7550 (-2.21%)
Pure Extracts Corporate Update

VANCOUVER, British Columbia, May 03, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp . (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”) is pleased to provide...

PSYG.CN : 0.180 (-5.26%)
PULL.CN : 0.135 (-3.57%)
PRXTF : 0.1130 (-3.42%)
Market For Psychedelic Drugs Expected to Reach $6.9 Billion By 2027

Palm Beach, FL – April 14, 2021 – The psychedelics industry may appear to have suddenly emerged as one of the hottest corners of the stock market, but researchers have been working for decades to show...

RVV.CN : 0.490 (+4.26%)
RVVTF : 0.3900 (+4.14%)
PHRM.CN : 0.405 (-5.81%)
PHRRF : 0.3219 (-9.17%)
PULL.CN : 0.135 (-3.57%)
PRXTF : 0.1130 (-3.42%)
PSYG.CN : 0.180 (-5.26%)
HAVN.CN : 0.225 (-2.17%)
HAVLF : 0.1800 (-9.09%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.197
2nd Resistance Point 0.193
1st Resistance Point 0.187
Last Price 0.180
1st Support Level 0.177
2nd Support Level 0.173
3rd Support Level 0.167

See More

52-Week High 0.620
Fibonacci 61.8% 0.421
Fibonacci 50% 0.360
Fibonacci 38.2% 0.299
Last Price 0.180
52-Week Low 0.100

See More

Business Summary

Psyence Group Inc is a science-led psychedelic platform led by experts in neurology, neuroscience, and drug development. The company builds and operates federally licensed commercial psilocybin cultivation and production facilities.

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar